Literature DB >> 17691936

Cross-talk between NO and arachidonic acid in inflammation.

Sofia Mariotto1, Ylenia Suzuki, Tiziana Persichini, Marco Colasanti, Hisanori Suzuki, Orazio Cantoni.   

Abstract

Inducible nitric oxide synthase (iNOS) is expressed in a variety of cell types, in particular in inflammatory cells, in response to diverse pro-inflammatory stimuli. This process requires critical levels of arachidonic acid (AA), generated by constitutive phospholipase A(2) (PLA(2)), promoting tyrosine kinase-dependent phosphorylation, and inhibition, of constitutive NOS. Lowering basal NO levels is indeed critical for the activation of nuclear factor-kappaB (NF-kappaB), and thus for the expression of genes (e.g. iNOS) regulated by this transcription factor. It is interesting to note that NO and AA, two small lipid soluble molecules, rapidly cross the plasma membrane thereby allowing the triggering of the above responses in distal cells. That is, constitutive NO might inhibit NF-kappaB activity in the same cells (e.g. astrocytes) in which it is generated, as well as in other cells that do not express constitutive NOS (e.g. microglia). NO from cells unable to respond to pro-inflammatory stimuli (e.g. neurons) will also contribute to these effects. Along the same line, AA released by pro-inflammatory molecules in specific cell types (e.g. astrocytes) might suppress constitutive NOS activity in the same cells as well as in other cells (e.g. neurons). Thus, AA produced at the very early stages of the inflammatory response is a likely critical signal switching the regulation of the "NO tone" from physiological (i.e. mediated by constitutive NOS) to pathological (i.e. mediated by iNOS). This second phase of the inflammatory response is often accompanied by the onset of deleterious effects in the tissue in which a critical role is played by iNOS-derived NO (directly or indirectly, i.e. via formation of peroxynitrite) as well as by products of the AA cascade. In summary, we suggest that the relative amounts of NO and AA, released by their constitutive enzymes, produce autocrine and paracrine effects regulating the onset of an inflammatory response in which, in addition to other factors, NO and AA are extensively released by their inducible enzymes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17691936     DOI: 10.2174/092986707781368531

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  15 in total

1.  Flavocoxid attenuates gentamicin-induced nephrotoxicity in rats.

Authors:  Dalia H El-Kashef; Asmaa E El-Kenawi; Ghada M Suddek; Hatem A Salem
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-15       Impact factor: 3.000

2.  Central CCL2 signaling onto MCH neurons mediates metabolic and behavioral adaptation to inflammation.

Authors:  Ophélia Le Thuc; Céline Cansell; Miled Bourourou; Raphaël Gp Denis; Katharina Stobbe; Nadège Devaux; Alice Guyon; Julie Cazareth; Catherine Heurteaux; William Rostène; Serge Luquet; Nicolas Blondeau; Jean-Louis Nahon; Carole Rovère
Journal:  EMBO Rep       Date:  2016-10-12       Impact factor: 8.807

3.  Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses.

Authors:  Hirokazu Ohtaki; Joni H Ylostalo; Jessica E Foraker; Andrew P Robinson; Roxanne L Reger; Seiji Shioda; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-15       Impact factor: 11.205

4.  Conjugated linoleic acids and CLA-containing phospholipids inhibit NO formation in aortic endothelial cells.

Authors:  Kimberly J Jenko; Jack Y Vanderhoek
Journal:  Lipids       Date:  2008-03-12       Impact factor: 1.880

5.  American ginseng preferentially suppresses STAT/iNOS signaling in activated macrophages.

Authors:  Tomonaga Ichikawa; Jinqing Li; Prakash Nagarkatti; Mitzi Nagarkatti; Lorne J Hofseth; Anthony Windust; Taixing Cui
Journal:  J Ethnopharmacol       Date:  2009-06-06       Impact factor: 4.360

6.  Phenotype of the Cyp1a1/1a2/1b1-/- triple-knockout mouse.

Authors:  Nadine Dragin; Zhanquan Shi; Rajat Madan; Christopher L Karp; Maureen A Sartor; Chi Chen; Frank J Gonzalez; Daniel W Nebert
Journal:  Mol Pharmacol       Date:  2008-03-27       Impact factor: 4.436

7.  Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages.

Authors:  D Altavilla; F Squadrito; A Bitto; F Polito; B P Burnett; V Di Stefano; L Minutoli
Journal:  Br J Pharmacol       Date:  2009-08       Impact factor: 8.739

8.  Anti-inflammatory Steroid from Phragmitis rhizoma Modulates LPS-Mediated Signaling Through Inhibition of NF-κB Pathway.

Authors:  Sook Jahr Park; Young Woo Kim; Moon Ki Park; Sung Hui Byun; Sang Chan Kim; Jong Rok Lee
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

9.  Observational study: daily treatment with a new compound "Tradamixina" plus serenoa repens for two months improved the lower urinary tract symptoms.

Authors:  Fabrizio Iacono; Domenico Prezioso; Ester Illiano; Antonio Ruffo; Giuseppe Romeo; Bruno Amato
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

10.  Retraction Note: Observational study: daily treatment with a new compound "tradamixina" plus serenoa repens for two months improved the lower urinary tract symptoms.

Authors:  Fabrizio Iacono; Domenico Prezioso; Ester Illiano; Antonio Ruffo; Giuseppe Romeo; Bruno Amato
Journal:  BMC Surg       Date:  2016-04-28       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.